Lenalidomide 15mg

DRUG2 trials

Sponsors

Boston VA Research Institute, Inc., Peter MacCallum Cancer Centre, Australia

Conditions

Hodgkin LymphomaLymphoma, T-Cell, CutaneousLymphoma, T-Cell, PeripheralMultiple Myeloma

Phase 1

Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma

CompletedNCT03302728

Peter MacCallum Cancer Centre, AustraliaHodgkin Lymphoma, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

Start: 2018-08-30End: 2021-08-02Updated: 2022-05-19

Phase 2

Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma

CompletedNCT01380106

Boston VA Research Institute, Inc.Multiple Myeloma

Start: 2010-08-31End: 2017-09-11Updated: 2021-01-25